Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TEK | Q02763 | 14/20 | 0.67 |
| ▸ | KDR | P35968 | 14/20 | 0.67 |
| ▸ | MMP1 | P03956 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.54 |
| ▸ | RAF1 | P04049 | 1/20 | 0.52 |
| ▸ | MTOR | P42345 | 1/20 | 0.51 |
| ▸ | BRAF | P15056 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14375457 | 0.93 | TEK (0.78) | TEKKDRMMP1MEN1NR1I2 | |
| SCHEMBL5344391 | 0.92 | TEK (0.68) | TEKKDRMMP1MEN1NR1I2 | |
| SCHEMBL7013839 | 0.89 | KDR (0.54) | TEKKDRMMP1MEN1NR1I2 | |
| SCHEMBL5345304 | 0.89 | TEK (0.72) | TEKKDRMMP1MEN1NR1I2 | |
| Hydrochloric Acid SCHEMBL5346759 | 0.88 | MMP1 (0.73) | TEKKDRMMP1MEN1NR1I2 | |
| SCHEMBL5341168 | 0.88 | TEK (0.87) | TEKKDRMMP1RAF1 | |
| SCHEMBL5345802 | 0.85 | LMNA (0.57) | TEKKDRMMP1MEN1NR1I2 | |
| SCHEMBL5359663 | 0.85 | TEK (0.82) | TEKKDRMMP1RAF1 | |
| Sulfuric Acid SCHEMBL5351981 | 0.85 | TEK (0.82) | TEKKDRMMP1RAF1 | |
| SCHEMBL14375456 | 0.84 | TEK (0.77) | TEKKDRMMP1MEN1NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070249600-A1 | CHEMICAL COMPOUNDS | CHEUNG MUI | 2007-10-25 | — | — | US | claimed |
| US-20040082583-A1 | Chemical compounds | SMITHKLINE BEECHAM CORPORATION | 2004-04-29 | — | — | US | claimed |
| US-20070249600-A1 | CHEMICAL COMPOUNDS | CHEUNG MUI | 2007-10-25 | — | — | US | disclosed |
| US-7238813-B2 | Chemical compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2007-07-03 | — | — | US | disclosed |
| US-20040082583-A1 | Chemical compounds | SMITHKLINE BEECHAM CORPORATION | 2004-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249600-A1 | CHEMICAL COMPOUNDS | TIE1, KDR, FLT4 | TEK 5/4885KDR 2/4885MMP1 2829/4885 |
| US-20040082583-A1 | Chemical compounds | TIE1, KDR, FLT4 | TEK 5/4885KDR 2/4885MMP1 2829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.